|
1
|
Tonacci A, Billeci L, Pioggia G, Navarra M, Gangemi S. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature. Pharmacotherapy 2017; 37:464-480. [DOI: 10.1002/phar.1915] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Alessandro Tonacci
- Clinical Physiology Institute; National Research Council of Italy (IFC-CNR); Pisa Italy
| | - Lucia Billeci
- Clinical Physiology Institute; National Research Council of Italy (IFC-CNR); Pisa Italy
| | - Giovanni Pioggia
- Institute of Applied Sciences and Intelligent Systems “Eduardo Caianiello” (ISASI); National Research Council of Italy (CNR); Messina Italy
| | - Michele Navarra
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences; University of Messina; Messina Italy
| | - Sebastiano Gangemi
- Institute of Applied Sciences and Intelligent Systems “Eduardo Caianiello” (ISASI); National Research Council of Italy (CNR); Messina Italy
- School and Division of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine; University Hospital “G. Martino”; Messina Italy
| |
Collapse
|